Endoscopic Iliotibial Band Lengthening and Bursectomy Effectively Improve Pain and Function in Patients With Greater Trochanteric Pain Syndrome Authors: Ashlyn A Callan, Brandon Boyd, Harrison Volaski, Yungtai Lo, Ethan Krell, Noel Akioyamen, Ferdinand J Chan Published: 2026 ABSTRACT AbstractPurposeTo evaluate patient‐reported outcomes after endoscopic bursectomy and iliotibial band lengthening for the treatment of greater trochanteric pain syndrome.MethodsPatients >18 years who underwent endoscopic bursectomy and iliotibial band lengthening for treatment of greater trochanteric pain syndrome were included. Patient‐reported outcomes were collected preoperatively and postoperatively at 1‐year follow‐up. Outcome measures included Hip Outcome Score Activity of Daily Living score and Sports subscales, modified Harris Hip Score, and University of California, Los Angeles activity score. Data was analyzed using Wilcoxon rank‐sum tests and Fisher's exact tests.ResultsThe study included 25 individual patients (17 preoperative and 13 postoperative data points; and 5 patients provided both). The cohort had a mean age of 53.6 years (range, 27‐86), and 73% were women. Significant improvements in functional scores were observed across all outcome measures. The median (interquartile range) total Hip Outcome Score Activity of Daily Living improved from 43.8 (27.9, 60.3) preoperatively to 91.2 (72.1, 95.6) postoperatively (P < .001). Hip Outcome Score‐Sports improved from 25.0 (5.0, 50.0) preoperatively to 80.0 (57.5, 97.5) postoperatively (P = .001). Level of function during usual activities improved from 45.0 (10.0, 50.0) to 80.0 (75.0, 95.0) (P = .001). Total function score improved from 34.5 (26.0, 56.8) to 90.2 (72.1, 92.3) (P = .001). The modified Harris Hip Score improved from 33.0 (24.0, 51.0) to 77.0 (53.0, 85.0) (P < .001). University of California, Los Angeles activity score improved from 3.0 (2.0, 4.0) preoperatively to 6.0 (3.0, 9.0) postoperatively (P = .028).ConclusionsEndoscopic bursectomy and iliotibial band lengthening were associated with improvements in patient‐reported pain and function in patients with chronic greater trochanteric pain syndrome. Although these results are compelling, they should be interpreted with caution because of the relatively small sample size.Level of EvidenceLevel IV, retrospective case series. Greater trochanteric pain syndrome (GTPS) is a clinical diagnosis encompassing iliotibial band (ITB) syndrome, trochanteric bursitis, and gluteal tendinopathy. Classically, it presents as lateral hip pain often because of overuse or degenerative changes. First‐line treatment is conservative, consisting of some combination of rest, activity modification, nonsteroidal anti‐inflammatory medication, and physical therapy. 1 There is a subset of patients who experience persistent debilitating pain and functional limitations despite appropriate first‐line therapeutic treatment. Previously, surgical treatment was limited to open techniques with significant associated risks, including complications such as chronic pain, infection, and bleeding. 2 Farr et al. reported on an endoscopic technique for GTPS, and similar endoscopic techniques have since been employed for treatment of external snapping hip syndrome and gluteus medius tendinopathy. 3 , 4 , 5 However, there is limited data comparing pre‐ and postoperative patient‐reported outcomes after bursectomy and ITB lengthening. The purpose of this study was to evaluate patient‐reported outcomes after endoscopic bursectomy and ITB lengthening for the treatment of GTPS. We hypothesize that endoscopic bursectomy and ITB lengthening will significantly improve pain and functional outcome scores. METHODS We performed a retrospective review of patients who underwent endoscopic bursectomy and ITB lengthening for treatment of GTPS and trochanteric bursitis between June 2021 and July 2024 at our institution. Patients were included if they were over the age of 18 years, had a diagnosis of GTPS refractory to conservative management, had self‐reported outcome data either during the preoperative period or at a minimum 1‐year postoperative period, and had demographic data available. The patient‐reported outcomes analyzed in our study included the subsets of the Hip Outcome Score (HOS), Activities of Daily Living (ADL) and Sports and Recreation (Sports), current level of function during usual activities, total function score, modified Harris Hip Score (mHHS), and University of California, Los Angeles (UCLA) activity score. Patients were excluded if they were under the age of 18, had high‐grade or complete gluteus medius tears, or had previous hip surgery. The cohort included both male and female patients. Patients were indicated for surgery because of GTPS and trochanteric bursitis that was refractory to conservative treatment. There is 1 surgeon at 1 institution who was included (F.J.C.), and the postoperative protocol was standardized for all patients. Prior to surgical intervention, all patients underwent a trial of nonoperative management for a minimum of 3 months. Conservative treatment included activity modification, nonsteroidal anti‐inflammatory medications as tolerated, and formal physical therapy focused on hip abductor strengthening, ITB stretching, core stabilization, and gait mechanics. In addition, all patients received at least 1 corticosteroid injection to the greater trochanteric bursa. Surgical intervention was considered only after failure of these conservative measures to provide sustained symptomatic relief. This study received Institutional Review Board approval. Surgical Technique The patient is positioned on a hip distractor table with the hip in slight abduction, with care taken to pad all body parts. Traction is not applied to either hip. The operative extremity is prepped and draped in a standard sterile fashion. Using bony landmarks and fluoroscopic guidance, a superior trochanteric portal is made 7 cm distal to the tip of the greater trochanter in the midline of the femur. Approximately 4 cm proximal to the greater trochanter, a proximal trochanteric portal is created. A 30° arthroscope is then introduced via the inferior trochanteric portal into the peritrochanteric space superficial to the ITB. Using a radiofrequency coblation device (Werewolf Coblation System, Smith & Nephew, Fremont, CA), the adipose tissue overlying the ITB is debrided to allow for direct visualization and identification of the ITB. Dissection is taken superiorly to 1 cm above the tip of the greater trochanter and 1 cm distal to the vastus ridge as visualized on fluoroscopy. With the ITB fully visualized, 4 points are marked for a cruciate to be made on the ITB. After the cruciate is made, a diamond is created by resecting the 4 triangles. An extensive greater trochanteric bursectomy is then performed with an electrocautery device placed first through the superior portal and then the distal portal. Switching to the distal portal allows the electrocautery device to be advanced along the vastus lateralis, rather than through the fibers of the gluteus medius muscle. After the bursectomy is completed, the hip is dynamically assessed in neutral abduction for residual impingement on the trochanter by internally and externally rotating the foot. Portal sites are then closed with 3‐0 nylon. A solution of 20 cc of 0.5% ropivacaine and 20 cc of 1% lidocaine with epinephrine is insufflated to the portal sites. A sterile dressing is then applied. Postoperative Rehabilitation Protocol Postoperatively, for the first 2 weeks, patients were weight‐bearing as tolerated with crutches and exercises focused on initiating early range of motion, quadriceps isometrics, and core strengthening. During weeks 3 through 6, patients were transitioned off crutches and progressed to active hip abductor strengthening and straight leg raises. After week 7, the protocol emphasized advancing gait mechanics, proprioceptive training, and stairclimber endurance. A return to sports and high‐impact activities was permitted once patients achieved symmetric strength and full, pain‐free function. Statistical analysis was performed using SPSS Statistics, with the Shapiro‐Wilk test used to assess data normality. Given the nonparametric distribution, primary outcomes including HOS‐ADL, HOS‐Sports, mHHS, and UCLA activity scores were reported as medians with interquartile ranges. Differences between the independent preoperative and postoperative cohorts were evaluated using the Wilcoxon rank‐sum test. Statistical significance was defined as a 2‐tailed P value of <.05 for all comparisons. RESULTS A total of 25 individual patients were included in the analysis (Figure 1). The cohort consisted of 17 preoperative data points and 13 postoperative data points. Twelve patients provided results exclusively for the preoperative period, 8 patients provided results exclusively for the postoperative period, and 5 patients provided results for both the pre‐ and postoperative period. Because most patients did not contribute both preoperative and postoperative outcome data, the following analyses reflect comparisons between independent cohorts rather than within‐patient longitudinal change. Overall, patients had a mean age of 53.6 years (range, 27‐86), and 73% were women. There was no significant difference in sex, age, race, or ethnicity between participant groups (Table 1). The dataset was not disaggregated by sex because of low participant numbers. Flowchart of inclusion and exclusion. (ITB, iliotibial band; PROs, patient‐reported outcomes.) TABLE 1Demographics in Preoperative and Postoperative GroupsPresurgery, n = 17Postsurgery, n = 13 P ValueAge, mean ± SD54 ± 16.749.3 ± 13.2.395Sex, n (%).407Female11 (64.7%)11 (84.6%)Male6 (35.3%)2 (15.4%)Race, n (%).527Black8 (47.0%)5 (38.5%)White2 (11.8%)0Other4 (23.5%)6 (46.1%)Declined3 (17.6%)2 (15.4%)Ethnicity, n (%).632Hispanic6 (35.3%)7 (53.8%)Non‐Hispanic7 (41.2%)4 (30.8%)Declined4 (23.55)2 (15.4%) Note: P values were obtained from the t‐test for age, Wilcoxon rank‐sum tests for other continuous variables, and Fisher's exact tests for categorical variables, under the assumption that the 2 groups were independent.SD, standard deviation. Demographics in Preoperative and Postoperative Groups Note: P values were obtained from the t‐test for age, Wilcoxon rank‐sum tests for other continuous variables, and Fisher's exact tests for categorical variables, under the assumption that the 2 groups were independent. SD, standard deviation. Statistically significant differences were observed across all patient‐reported outcome measures between the preoperative and postoperative cohorts (Table 2). The median (interquartile range) total HOS‐ADL score was 43.8 (27.9, 60.3) for the preoperative cohort and 91.2 (72.1, 95.6) for the postoperative cohort (P < .001). Significant differences were noted in the level of function during sports (HOS‐Sports), increasing from 25.0 (5.0, 50.0) to 80.0 (57.5, 97.5) (P = .001). Median current level of function during usual activities improved from 45.0 (10.0, 50.0) for the preoperative cohort to 80.0 (75.0, 95.0) for the postoperative cohort (P = .001). The median total function score improved from 34.5 (26.0, 56.8) for the preoperative cohort to 90.2 (72.1, 92.3) for the postoperative cohort (P = .001). The median mHHS increased from 33.0 (24.0, 51.0) for the preoperative cohort to 77.0 (53.0, 85.0) for the postoperative cohort (P < .001). The UCLA activity score also saw significant improvement from 3.0 (2.0, 4.0) to 6.0 (3.0, 9.0) (P = .028). The data was compared using Wilcoxon rank‐sum tests, which were used to compare the 2 cohorts under the assumption of independence. TABLE 2Functional Scores in Preoperative and Postoperative GroupsPresurgery, n = 17Postsurgery, n = 13 P ValueTotal ADL score, median (IQR)43.8 (27.9, 60.3)91.2 (72.1, 95.6)<.001Current level of function during usual activities, median (IQR)45.0 (10.0, 50.0)80.0 (75.0, 95.0).001Total function score, median (IQR)34.5 (26.0, 56.8)90.2 (72.1, 92.3).001Current level of function during sports, median (IQR)25.0 (5.0, 50.0)80.0 (57.5, 97.5).001Modified Harris hip score, median (IQR)33.0 (24.0, 51.0)77.0 (53.0, 85.0)<.001UCLA activity scale, median (IQR)3.0 (2.0, 4.0)6.0 (3.0, 9.0).028 Note: P values were obtained from the t‐test for age, Wilcoxon rank‐sum tests for other continuous variables, and Fisher's exact tests for categorical variables, under the assumption that the 2 groups were independent.ADL, Activities of Daily Living; IQR, interquartile range; SD, standard deviation; UCLA, University of California, Los Angeles. Functional Scores in Preoperative and Postoperative Groups Note: P values were obtained from the t‐test for age, Wilcoxon rank‐sum tests for other continuous variables, and Fisher's exact tests for categorical variables, under the assumption that the 2 groups were independent. ADL, Activities of Daily Living; IQR, interquartile range; SD, standard deviation; UCLA, University of California, Los Angeles. DISCUSSION The principal finding of this study is that patients in the postoperative cohort showed significantly higher patient‐reported pain and function scores compared with the preoperative cohort after endoscopic bursectomy and ITB lengthening. GTPS is an overuse condition commonly causing lateral hip pain. Previous control of symptoms had been limited to conservative methods such as rest, nonsteroidal anti‐inflammatory medication, and physical therapy. 1 These conservative methods are often successful, with 1 study reporting that 70% of cases are well managed through conservative methods alone. 6 Previous research has also suggested that surgical management can be highly effective for GTPS, but historically, surgical management involved open techniques. 5 This is consistent with evidence that GTPS can be caused by proximal IT band thickening, especially in those who fail conservative treatment. 7 There are both open and endoscopic surgical techniques that can be used for this treatment, and minimally invasive endoscopic approaches have proven successful in limiting soft tissue damage and blood loss. 8 The indications for endoscopic trochanteric bursectomy with ITB lengthening in this study were limited to patients with GTPS without high‐grade or complete gluteus medius tears. Patients with low‐grade or partial‐thickness gluteus medius tears who underwent microtenotomy and microfracture with a 2.0‐mm K‐wire were not included in this study. Similarly, gluteus maximus sling release was not performed in this cohort and is reserved for patients with refractory external snapping hip or isolated mechanical symptoms attributable to gluteus maximus tendon pathology rather than primary peritrochanteric pain. These criteria underscore the importance of tailoring surgical intervention to the underlying pathology in patients with lateral hip pain. Additionally, outcomes have been shown in a systematic review to greatly vary by patient selection. 9 Findings by Lustenberger et al. have shown that endoscopic surgical treatment improves outcomes more than conservative management for trochanteric bursitis. 5 An additional case series found that endoscopic bursectomy and ITB lengthening have been shown to improve symptoms in external snapping hip syndrome, which is similar to GTPS. 10 , 11 The statistically significant improvements in HOS‐ADL, HOS‐Sports, and mHHS scores are particularly noteworthy. The leap in median HOS‐ADL scores (from 43.8 to 91.2) suggests a transition from significant disability to near‐normal daily function. The improvement in the UCLA activity score also indicates that patients were able to return to higher levels of physical exertion, which is often the primary goal for the active demographic seen in this study (mean age 53.6). These findings are consistent with prior literature suggesting that surgical management may benefit select patients with GTPS who fail conservative treatment. In summary, endoscopic bursectomy and ITB lengthening are associated with improvements in patient‐reported pain and function in patients with chronic, recalcitrant GTPS. Although a cohort‐specific minimal clinically important difference (MCID) could not be calculated because of the lack of paired longitudinal data, the magnitude of observed differences exceeds commonly reported MCID thresholds in prior literature, suggesting potential clinical relevance while remaining hypothesis‐generating. Given the limited outcome data for patients with chronic GTPS and trochanteric bursitis that is recalcitrant to conservative treatment subsequently undergoing endoscopic surgical bursectomy and ITB lengthening, these findings should be seen as encouraging but preliminary evidence of this procedure's efficacy. Therefore, future prospective randomized controlled trials with larger paired cohorts are needed to further validate the long‐term efficacy and reproducibility of endoscopic bursectomy and ITB lengthening. Limitations Our data must be considered within the context of its limitations. First, our primary outcome relies on patient‐reported pain and function scores. Self‐reported data is inherently subjective and thus may introduce reporting bias. We did not analyze results by sex because of an already small sample size. Additionally, because of feasibility constraints, participants were not matched across pre‐ and postoperative periods. This is because of many patients opting not to come in for a 1‐year follow‐up visit after reporting no issues at their 6‐month postop visit. Only 5 participants were included in both groups. This introduces the possibility of confounding variables affecting outcome data; however, we found no differences in the demographics between the 2 groups. Furthermore, a cohort‐specific MCID analysis was not performed; because most participants were not longitudinally linked, the subject‐level change scores required to calculate a distribution‐based MCID were unavailable. The small sample size and the use of only 1 physician's practice in this study may also limit the generalizability of the findings to a broader patient population. CONCLUSIONS Endoscopic bursectomy and ITB lengthening were associated with improvements in patient‐reported pain and function in patients with chronic GTPS. Although these results are compelling, they should be interpreted with caution because of the relatively small sample size. DISCLOSURES The authors (A.A.C., F.J.C.) declare the following financial interests/personal relationships which may be considered as potential competing interests: A.A.C. reports a relationship with Abbott that includes: equity or stocks. F.J.C. is a reviewer for the Journal of the American Academy of Orthopaedic Surgeons. The other authors (B.B., H.V., Y.L., E.K., N.A.) declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article. REFERENCES